Clinical Trials Logo

Clinical Trial Summary

Human papillomaviruses (HPVs) are the most common of sexually transmitted viral agents and they are associated with genital and oral diseases. Agreement between cervical and oral HPV infection has been described from a small group of patient. Our study, performed on a greater number of patients, will provide a good estimation of this link, between cervical and oral infection, in a French population of women with a primary cervical HPV infection.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02774538
Study type Interventional
Source Institut de Cancérologie de Lorraine
Contact
Status Completed
Phase N/A
Start date May 11, 2016
Completion date April 2022

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03180034 - Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study Phase 4
Active, not recruiting NCT00867464 - Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
Active, not recruiting NCT03634267 - MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer Phase 1
Active, not recruiting NCT03728881 - Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial Phase 3